Oncology
Consultant Medical Oncologist14+ Years of Experience in Medical Oncology, Radiation Oncology and Comprehensive Cancer Care.
HCG Cancer Centre
Kolkata
Dr. Debanti Banerjee is an experienced Medical Oncologist in Kolkata with expertise in the diagnosis and treatment of solid tumors and hematological cancers. She currently practices at HCG Cancer Centre, New Town, and RB Diagnostic, Lake Town, Kolkata.
She completed her MBBS and MD in Radiation Oncology from R.G. Kar Medical College, Kolkata, followed by DNB in Radiation Oncology from the National Board of Examination, New Delhi. She later pursued DM in Medical Oncology from Gujarat Cancer & Research Institute, Ahmedabad, and is also certified by the European Society for Medical Oncology.
Dr. Debanti Banerjee has extensive experience in chemotherapy, immunotherapy, targeted therapy, hormone therapy and personalized cancer treatment. Her clinical practice includes treatment planning for breast cancer, lung cancer, gastrointestinal cancers, gynecological cancers, head and neck cancers and genitourinary malignancies.
She also manages hematological malignancies including leukemia, lymphoma and multiple myeloma. Her approach focuses on evidence-based oncology protocols, molecular profiling and individualized treatment planning according to cancer type, stage and patient condition.
Her areas of interest also include advanced cancer treatment approaches such as HIPEC and PIPAC for selected abdominal and peritoneal malignancies. She has received oncology fellowships and preceptorships from professional organizations including ESMO, AROI and ISMPO.
Dr. Banerjee combines medical oncology expertise with a multidisciplinary approach to cancer care, helping patients understand their diagnosis, available treatment options and long-term management plan.
Chemotherapy uses anti-cancer medicines to destroy or control cancer cells. Dr. Debanti Banerjee plans chemotherapy according to the cancer type, stage, overall health and treatment goals of each patient.
Immunotherapy helps the immune system identify and attack cancer cells and may be used for selected cancers based on biomarker testing, disease stage and previous treatments.
Targeted therapy uses medicines designed to act on specific molecular or genetic changes within cancer cells. Molecular testing may help determine whether a patient is suitable for targeted treatment.
Hormone therapy is used for hormone-sensitive cancers such as selected breast and prostate cancers. Treatment aims to reduce or block hormonal stimulation of cancer cells.
Breast cancer treatment may include chemotherapy, targeted therapy, immunotherapy and hormone therapy depending on tumor subtype, stage, receptor status and individual patient factors.
Lung cancer treatment is planned according to cancer type, stage and molecular test results and may involve chemotherapy, immunotherapy, targeted therapy or combinations of these treatments.
Head and neck cancer treatment may involve systemic therapies such as chemotherapy, immunotherapy or targeted therapy as part of a multidisciplinary cancer treatment plan.
Gastrointestinal cancers include cancers of the stomach, colon, rectum, pancreas and other digestive organs. Treatment is selected according to disease location, stage and molecular characteristics.
Colorectal cancer may be treated using chemotherapy, targeted therapy or immunotherapy depending on disease stage, molecular markers and the patient's overall treatment plan.
Ovarian cancer treatment may include chemotherapy and targeted medicines, with treatment selected according to disease stage, pathology and genetic or molecular findings.
Cervical cancer treatment may involve chemotherapy, immunotherapy and other systemic treatments depending on disease stage, previous therapy and overall clinical condition.
Medical treatment for prostate cancer can include hormone therapy, chemotherapy and newer targeted therapies depending on cancer stage, disease progression and patient health.
Leukemia treatment may include chemotherapy, targeted therapy and immunotherapy depending on the leukemia subtype, disease risk and individual treatment response.
Lymphoma treatment is planned based on whether the disease is Hodgkin or non-Hodgkin lymphoma, along with subtype, stage and overall patient health.
Multiple myeloma treatment may include targeted medicines, immunomodulatory treatment and chemotherapy according to disease status and patient fitness.
Hyperthermic intraperitoneal chemotherapy is an advanced treatment used in selected abdominal cancers where heated chemotherapy is delivered directly into the abdominal cavity as part of a specialized treatment strategy.
Pressurized intraperitoneal aerosol chemotherapy is an advanced approach in which chemotherapy is delivered as a pressurized aerosol into the abdominal cavity for selected peritoneal cancers.
Personalized cancer treatment considers cancer type, stage, molecular profile, previous treatments and individual patient factors to select the most appropriate systemic therapy.
MBBS, MD (Radiation Oncology), DNB (Radiation Oncology), DM (Medical Oncology), ESMO Certified
Chemotherapy, Immunotherapy, Targeted Therapy, Hormone Therapy, Precision Oncology, Breast Cancer Treatment
Genuine patient experiences and treatment feedback.
Quick answers to common questions about Dr. Debanti Banerjee
Dr. Debanti Banerjee is a Medical Oncologist in Kolkata with expertise in chemotherapy, immunotherapy, targeted therapy, hormone therapy and comprehensive cancer management.
Dr. Debanti Banerjee specialises in Medical Oncology and has additional training and experience in Radiation Oncology.
Dr. Debanti Banerjee holds MBBS, MD in Radiation Oncology, DNB in Radiation Oncology and DM in Medical Oncology qualifications. She is also ESMO certified.
Dr. Debanti Banerjee has more than 14 years of experience in oncology and cancer care.
She practices at HCG Cancer Centre, New Town, Kolkata, and RB Diagnostic, Lake Town.
Contact us for personalized help or to schedule an appointment.